Literature DB >> 14502093

Adenosine A3 receptors are located in neurons of the rat hippocampus.

Luísa V Lopes1, Nelson Rebola, Paulo C Pinheiro, Peter J Richardson, Catarina R Oliveira, Rodrigo A Cunha.   

Abstract

Adenosine is a neuromodulator acting mainly via inhibitory A1 and facilitatory A2A receptors. Whole tissue PCR also identified adenosine A3 receptors in the brain and A3 receptor agonists affect CNS neuronal responses and viability. However, recent reports failed to detect A3 receptor expression in CNS neurons and showed that A3 receptor agonists can bind and activate A1 receptors. We now present evidence for the presence of A3 receptor mRNA in CNS neurons using single cell PCR analysis of laser dissected hippocampal neurons. Western blot analysis showed that A3 receptors are present in rat hippocampal nerve terminal membranes. This indicates that A3 receptors are present in CNS neurons in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14502093     DOI: 10.1097/00001756-200308260-00021

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  30 in total

1.  Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus.

Authors:  Ricardo J Rodrigues; Teresa Almeida; Peter J Richardson; Catarina R Oliveira; Rodrigo A Cunha
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

Review 2.  Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.

Authors:  Kenneth A Jacobson; Athena M Klutz; Dilip K Tosh; Andrei A Ivanov; Delia Preti; Pier Giovanni Baraldi
Journal:  Handb Exp Pharmacol       Date:  2009

3.  Colocalization and regulated physical association of presynaptic serotonin transporters with A₃ adenosine receptors.

Authors:  Chong-Bin Zhu; Kathryn M Lindler; Nicholas G Campbell; James S Sutcliffe; William A Hewlett; Randy D Blakely
Journal:  Mol Pharmacol       Date:  2011-06-24       Impact factor: 4.436

Review 4.  Adverse and protective influences of adenosine on the newborn and embryo: implications for preterm white matter injury and embryo protection.

Authors:  Scott A Rivkees; Christopher C Wendler
Journal:  Pediatr Res       Date:  2011-04       Impact factor: 3.756

5.  Role of nitric oxide in the behavioral and neurochemical effects of IB-MECA in zebrafish.

Authors:  Caio Maximino; Julliany Gemaque; Rancés Benzecry; Monica Gomes Lima; Evander de Jesus Oliveira Batista; Domingos Wanderley Picanço-Diniz; Karen Renata Matos Oliveira; Anderson Manoel Herculano
Journal:  Psychopharmacology (Berl)       Date:  2014-11-13       Impact factor: 4.530

6.  A3 adenosine receptor agonist attenuates neuropathic pain by suppressing activation of microglia and convergence of nociceptive inputs in the spinal dorsal horn.

Authors:  Ryuji Terayama; Mitsuyasu Tabata; Kotaro Maruhama; Seiji Iida
Journal:  Exp Brain Res       Date:  2018-09-11       Impact factor: 1.972

Review 7.  Regulation of cardiovascular development by adenosine and adenosine-mediated embryo protection.

Authors:  Scott A Rivkees; Christopher C Wendler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

8.  Adenosine A2B and A3 receptor location at the mouse neuromuscular junction.

Authors:  Neus Garcia; Mercedes Priego; Erica Hurtado; Teresa Obis; Manel M Santafe; Marta Tomàs; Maria Angel Lanuza; Josep Tomàs
Journal:  J Anat       Date:  2014-04-23       Impact factor: 2.610

9.  Controlling murine and rat chronic pain through A3 adenosine receptor activation.

Authors:  Zhoumou Chen; Kali Janes; Collin Chen; Tim Doyle; Leesa Bryant; Dilip K Tosh; Kenneth A Jacobson; Daniela Salvemini
Journal:  FASEB J       Date:  2012-02-17       Impact factor: 5.191

10.  Enhanced neurodegeneration after a high dose of methamphetamine in adenosine A3 receptor null mutant mice.

Authors:  H Shen; Y Luo; S-J Yu; Y Wang
Journal:  Neuroscience       Date:  2011-08-10       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.